Synlogic

$4.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.18 (-4.22%) Today

$0.00 (0.00%) As of 12:34 PM UTC after-hours

Why Robinhood?

You can buy or sell Synlogic and other stocks, options, and ETFs commission-free!

About SYBX

Synlogic, Inc. Common Stock, also called Synlogic, is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA. The listed name for SYBX is Synlogic, Inc. Common Stock.

CEO

Aoife M. Brennan

Employees

Headquarters

Cambridge, Massachusetts

Founded

2017

Market Cap

128.12M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

4.68M

High Today

$4.25

Low Today

$3.95

Open Price

$4.14

Volume

520.36K

52 Week High

$4.30

52 Week Low

$1.35

Collections

Analyst Ratings

83%

of 6 ratings

Buy

83%

Hold

17%

Sell

SYBX Earnings

-$0.49

-$0.33

-$0.16

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, Pre-Market